tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
15Bullish
2Neutral
5Bearish
Oscillators
Sell
3Bullish
2Neutral
5Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.34, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 22.55, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 22.07, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Dec 01, 2025, 10:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.30
23.30
23.30
23.30
23.30
23.30
23.30
Fibonacci
23.30
23.30
23.30
23.30
23.30
23.30
23.30

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Dec 01, 2025, 10:41 AM
Period
Simple
Exponential
MA5
23.18Buy
23.13Buy
MA10
22.73Buy
22.85Buy
MA20
22.35Buy
22.55Buy
MA50
22.05Buy
22.07Buy
MA100
21.39Buy
21.48Buy
MA200
20.11Buy
20.58Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 22.85, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 21.48, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 22.05, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 21.39, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 20.11, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Dec 01, 2025, 10:41 AM
Name
Value
Action
RSI (14)
67.35
Neutral
STOCH (9,6)
98.61
Sell
STOCHRSI (14)
98.65
Sell
MACD (12,26)
0.34
Sell
ADX (14)
21.20
Neutral
Williams %R
-2.75
Sell
CCI (14)
154.23
Sell
ATR (14)
0.20
-
Ultimate Oscillator
83.32
Buy
ROC
7.17
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 67.35, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 21.20, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 154.23, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 7.17, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 67.35, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.34, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 23.18, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 22.35, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 22.05, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 20.11, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -2.75, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 154.23, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement